Alteryx Case Studies Life Altering Analysis to Catch a Predatory Pharmacy

Edit This Case Study Record

	Life Altering Analysis to Catch a Predatory Pharmacy Alteryx

Life Altering Analysis to Catch a Predatory Pharmacy

Alteryx

Technology Category	Analytics & Modeling - Big Data Analytics
Applicable Industries	Healthcare & Hospitals
Applicable Functions	Procurement
Use Cases	Fraud Detection Predictive Quality Analytics
Services	Data Science Services
Challenge	In early 2017, SCAN, a non-profit Medicare Advantage organization serving California, started receiving reports from members about receiving unwanted Lidocaine ointments by mail. This scheme had started affecting the industry in 2015, but had not yet impacted SCAN at a significant scale. The challenge was to identify the source of this scheme and stop it from further affecting the members and the organization financially. The Special Investigations Unit at SCAN was tasked with investigating these allegations that might have an adverse financial or compliance impact on members or the program. The team had to figure out the chances of one member being served by many pharmacies, dozens of members going to the same pharmacy outside California, every patient getting the same high quality, and several pharmacies sharing the same address. Read More
About Customer	SCAN is a non-profit Medicare Advantage organization serving California. The organization serves approximately 200,000 members, largely in the Southern California region. The Centers of Medicare and Medicaid require health plans to have a fraud, waste, and abuse program. SCAN achieves this through the Special Investigations Unit. This unit investigates allegations that might have an adverse financial or compliance impact on members or the program. The team is responsible for identifying and addressing issues that could potentially harm the organization or its members. Read More
Solution	The Special Investigations Unit at SCAN used Alteryx, a data analytics platform, to investigate the allegations. The team used the network analysis tool in Alteryx to identify abnormal behavior and prioritize resources and investigations. The tool helped them visualize normal behavior versus abnormal behavior and identify more pharmacies with similar practices. The team also used Alteryx to monitor prescriptions for 1,000 affected members weekly for the same dispensing patterns from new pharmacies and adjust for new schemes. They also used Alteryx for spatial analysis, mapping distance and drive time for potential drug-seeking members and those receiving prescriptions or services from out of area. They also integrated with third-party data sources, retrieving data from regulatory bodies. Read More Log in to view content
Contents

Technology Category

Analytics & Modeling - Big Data Analytics

Applicable Industries

Healthcare & Hospitals

Applicable Functions

Procurement

Use Cases

Fraud Detection

Predictive Quality Analytics

Services

Data Science Services

Challenge

In early 2017, SCAN, a non-profit Medicare Advantage organization serving California, started receiving reports from members about receiving unwanted Lidocaine ointments by mail. This scheme had started affecting the industry in 2015, but had not yet impacted SCAN at a significant scale. The challenge was to identify the source of this scheme and stop it from further affecting the members and the organization financially. The Special Investigations Unit at SCAN was tasked with investigating these allegations that might have an adverse financial or compliance impact on members or the program. The team had to figure out the chances of one member being served by many pharmacies, dozens of members going to the same pharmacy outside California, every patient getting the same high quality, and several pharmacies sharing the same address.

About Customer

SCAN is a non-profit Medicare Advantage organization serving California. The organization serves approximately 200,000 members, largely in the Southern California region. The Centers of Medicare and Medicaid require health plans to have a fraud, waste, and abuse program. SCAN achieves this through the Special Investigations Unit. This unit investigates allegations that might have an adverse financial or compliance impact on members or the program. The team is responsible for identifying and addressing issues that could potentially harm the organization or its members.

Solution

The Special Investigations Unit at SCAN used Alteryx, a data analytics platform, to investigate the allegations. The team used the network analysis tool in Alteryx to identify abnormal behavior and prioritize resources and investigations. The tool helped them visualize normal behavior versus abnormal behavior and identify more pharmacies with similar practices. The team also used Alteryx to monitor prescriptions for 1,000 affected members weekly for the same dispensing patterns from new pharmacies and adjust for new schemes. They also used Alteryx for spatial analysis, mapping distance and drive time for potential drug-seeking members and those receiving prescriptions or services from out of area. They also integrated with third-party data sources, retrieving data from regulatory bodies.

Impact #1	Helped to 'stop the bleeding' and prevent further financial loss.
Impact #2	Enabled the team to understand the landscape and plan long-term.
Impact #3	Allowed the team to deliver feedback on vulnerabilities and conduct more complex analyses.

Impact #1

Helped to 'stop the bleeding' and prevent further financial loss.

Impact #2

Enabled the team to understand the landscape and plan long-term.

Impact #3

Allowed the team to deliver feedback on vulnerabilities and conduct more complex analyses.

Benefit #1	Projected cost avoidance for 2017 was upwards of $1.5 million.
Benefit #2	In 2018, the projected cost avoidance was $1 million.

Benefit #1

Projected cost avoidance for 2017 was upwards of $1.5 million.

Benefit #2

In 2018, the projected cost avoidance was $1 million.

Download PDF Version

Overview

Life Altering Analysis to Catch a Predatory Pharmacy

Operational Impact

Quantitative Benefit